← back to search

Bin Xu

Nanjing University of Chinese Medicine · CN
Area of research
Physiology · Cancer Research
Research interest
Research interests include Body Composition Measurement Techniques, Nutrition and Health in Aging, Thermoregulation and physiological responses, and MicroRNA in disease regulation.
h-index
45
citations
8,894
works
517
NIH funding
primary concept
email

Recent publications

Anti-Triggering Receptor Expressed on Myeloid Cells 2-Conjugated Nanovesicles Loaded Vadimezan Reprogram Tumor-Associated Macrophages to Combat Recurrent Lung Cancer
ACS Nano 2025cited by 5position: firstdoi
Bifidobacterium longum suppresses colorectal cancer through the modulation of intestinal microbes and immune function
Frontiers in Microbiology 2024cited by 26position: middledoi
LncRNA DDX11-AS1 promotes breast cancer progression by targeting the miR-30c-5p/MTDH axis
Scientific Reports 2024cited by 2position: middledoi
438TiP Trastuzumab deruxtecan with pyrotinib in first-line HER2-positive unresectable or metastatic breast cancer: An exploratory, multi-center, single-arm, phase II study (TROPHY, trial in progress)
Annals of Oncology 2024cited by 1position: lastdoi
LncRNA DDX11-AS1 promotes breast cancer progression via targeting the miR-30c-5p/MTDH axis
Research Square 2024cited by 0position: middledoi
A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy
Bioactive Materials 2023cited by 28position: firstdoi
Effects of Chinese heart-healthy diet on blood lipids, glucose, and estimated 10-y cardiovascular disease risk among Chinese adults: results on secondary outcomes of a randomized controlled trial
American Journal of Clinical Nutrition 2023cited by 12position: middledoi
Visualization of the relationship between fungi and cancer from the perspective of bibliometric analysis
Heliyon 2023cited by 12position: middledoi
Metadherin inhibits chemosensitivity of triple‐negative breast cancer to paclitaxel via activation of AKT/GSK‐3β signaling pathway
Chemical Biology & Drug Design 2023cited by 8position: middledoi
Calcium dobesilate prevents PLD-induced hand-foot syndrome by alleviating capillary endothelial tight junction injury via the HA/CD44 pathway.
PubMed 2023cited by 0position: middle
A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease
Journal of Nanobiotechnology 2022cited by 69position: middledoi
Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
Frontiers in Oncology 2022cited by 20position: middledoi
miR‑217‑5p suppresses epithelial‑mesenchymal transition and the NF‑κB signaling pathway in breast cancer via targeting of metadherin
Oncology Letters 2022cited by 10position: middledoi
Metadherin inhibits triple-negative breast cancer chemosensitivity to paclitaxel via activation of the AKT/GSK-3β signaling pathway
Research Square 2022cited by 1position: middledoi
Additional file 7 of Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway
Open MIND 2022cited by 0position: middledoi
Additional file 6 of Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway
Figshare 2022cited by 0position: middledoi
Diagnostic Value of Angiography-Derived IMR for Coronary Microcirculation and Its Prognostic Implication After PCI
Frontiers in Cardiovascular Medicine 2021cited by 47position: middledoi
Ginsenoside compound K exerts antitumour effects in renal cell carcinoma via regulation of ROS and lncRNA THOR
Oncology Reports 2021cited by 20position: middledoi
Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study
Cancer Management and Research 2021cited by 13position: middledoi
Bortezomib alleviates antibody‐mediated rejection in kidney transplantation by facilitating Atg5 expression
Journal of Cellular and Molecular Medicine 2021cited by 13position: middledoi
Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis
Journal of Experimental & Clinical Cancer Research 2020cited by 418position: middledoi
Diagnostic Performance of Contrast-Enhanced Ultrasound in Renal Cancer: A Meta-Analysis
Frontiers in Oncology 2020cited by 29position: middledoi
CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
Frontiers in Oncology 2019cited by 79position: middledoi
Micro-Ultrasound Imaging for Accuracy of Diagnosis in Clinically Significant Prostate Cancer: A Meta-Analysis
Frontiers in Oncology 2019cited by 27position: middledoi
Tagging SNPs in the HOTAIR gene are associated with bladder cancer risk in a Chinese population
Gene 2018cited by 20position: middledoi
miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma
OncoTargets and Therapy 2017cited by 43position: lastdoi
MicroRNA-21 Inhibits the Apoptosis of Osteosarcoma Cell Line SAOS-2 via Targeting Caspase 8
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017cited by 20position: firstdoi
Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research 2016cited by 55position: middledoi
Role of the functional variant (−652T>G) in the XRCC4 promoter in prostate cancer
Molecular Biology Reports 2014cited by 16position: middledoi
Effect of miR-146a polymorphism on biochemical recurrence risk after radical prostatectomy in southern Chinese population
Genetics and Molecular Research 2014cited by 9position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Ming Chen · Wuxi People's Hospital6 papers (2019–2022)Zhenchuan Song · Hebei Medical University6 papers (2022–2024)Lixian Yang · Zhejiang Provincial People's Hospital5 papers (2022–2024)Yang Liu · Hebei Medical University4 papers (2022–2024)Shuo Liu · National Clinical Research3 papers (2022–2024)Xinyu Huang · The First Affiliated Hospital, Sun Yat-sen University3 papers (2016–2020) · 3 papers (2019–2022)Shuqiu Chen · Houston Methodist3 papers (2021–2022)Xiu−Yan Huang · Shanghai Jiao Tong University3 papers (2016–2020)Weizhang Xu · Nanjing Medical University2 papers (2022–2022)Haijun Zhao · Hebei Medical University2 papers (2024–2024)Yan Chang · Hebei Medical University2 papers (2022–2023)Xiaolong Li · Central South University2 papers (2024–2024)Zhipeng Xu · Guangzhou University of Chinese Medicine2 papers (2022–2022)Yanting Li · Qingdao University2 papers (2024–2024)Jin Huang · Shanghai Jiao Tong University2 papers (2019–2020)Mengsi Zhou · Wenzhou University2 papers (2024–2024)Hui Chen · Zhejiang A & F University2 papers (2022–2022)Huili Wang · Guangzhou University of Chinese Medicine2 papers (2023–2025) · 2 papers (2022–2022)